Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Other Working Capital Changes (2022 - 2025)

Historic Other Working Capital Changes for CervoMed (CRVO) over the last 9 years, with Q3 2025 value amounting to $16828.0.

  • CervoMed's Other Working Capital Changes fell 2838.84% to $16828.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $16828.0, marking a year-over-year decrease of 2838.84%. This contributed to the annual value of $23568.0 for FY2024, which is 9803.62% down from last year.
  • CervoMed's Other Working Capital Changes amounted to $16828.0 in Q3 2025, which was down 2838.84% from $16828.0 recorded in Q2 2025.
  • In the past 5 years, CervoMed's Other Working Capital Changes ranged from a high of $960824.0 in Q2 2023 and a low of -$348917.0 during Q4 2023
  • Over the past 4 years, CervoMed's median Other Working Capital Changes value was $16828.0 (recorded in 2025), while the average stood at $194848.3.
  • Examining YoY changes over the last 5 years, CervoMed's Other Working Capital Changes showed a top increase of 36944769.23% in 2023 and a maximum decrease of 954783.6% in 2023.
  • Quarter analysis of 4 years shows CervoMed's Other Working Capital Changes stood at $26392.0 in 2022, then crashed by 1422.06% to -$348917.0 in 2023, then surged by 83.53% to -$57456.0 in 2024, then skyrocketed by 129.29% to $16828.0 in 2025.
  • Its Other Working Capital Changes was $16828.0 in Q3 2025, compared to $16828.0 in Q2 2025 and -$201613.0 in Q1 2025.